Revenio Group: Managers' Transactions - Caravelle Capital SAS

Revenio Group Corporation | Stock Exchange Release | October 06, 2026 at 11:00:00 EEST

Person subject to the notification requirementName: Caravelle Capital SASPosition: Closely associated person (X)Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Charles VilgrainPosition: Member of the BoardIssuer: Revenio Group OyjLEI: 743700I27E0FWSXLKK04Notification type: INITIAL NOTIFICATIONReference number: 175372/5/4____________________________________________Transaction date: 2026-09-29Outside a trading venueInstrument type: SHAREISIN: FI0009010912Nature of transaction: SUBSCRIPTION

Transaction details (1):Volume: 676776 Unit price: 6.19 EUR

Aggregated transactions (1):Volume: 676776 Volume weighted average price: 6.19 EUR

For further information, please contactCFO Jukka Kainulainen+358 9 8775 1150[email protected] DistributionNasdaq Helsinki OyFinancial Supervisory Authority (FIN-FSA)Principal mediawww.reveniogroup.fi/en 

Revenio Group in briefRevenio is a leading turnkey solutions provider in the global eye care market. The group offers fast, user-friendly, and reliable tools for diagnosing a wide variety of eye diseases. Revenio’s solutions include e.g. tonometers, fundus imaging devices, optical coherence tomography (OCT), perimeters, multimodal devices, refraction systems, and software solutions under iCare and Visionix. 

In May 2026, Revenio joined forces with Visionix, creating the most innovative, creative and comprehensive entity serving eye care professionals across optometry, optical retail and ophthalmology. In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. In 2025, the Group’s pro forma net sales totaled EUR 252.8 million, with a pro forma adjusted EBITDA of EUR 45.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V. 

Attachments

Managers' Transactions - Caravelle Capital SAS